Prostate Cancer - Results from #100

Developments in MRI-targeted prostate biopsy. October 28, 2019

Prostate-specific membrane antigen-targeted endoradiotherapy in metastatic prostate cancer. October 28, 2019

Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease? October 28, 2019

Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts. October 28, 2019

Effect of a Prospective Opioid Reduction Intervention on Opioid Prescribing and Use after Radical Prostatectomy: Results of the ORIOLES Initiative. October 25, 2019

Update of the AUA Policy Statement on the Use of Multiparametric Magnetic Resonance Imaging in the Diagnosis, Staging and Management of Prostate Cancer. October 25, 2019

A Novel Predictor Tool of Biochemical Recurrence after Radical Prostatectomy Based on a Five-MicroRNA Tissue Signature. October 25, 2019

TheraP: a randomized phase 2 trial of 177 Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). October 25, 2019

Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer: Results from the Dutch Castration-resistant Prostate Cancer Registry. October 25, 2019

Exposure-response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer. October 24, 2019

High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer. October 24, 2019

Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer. October 24, 2019

Towards precision oncology in advanced prostate cancer. October 24, 2019

MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate Cancer. October 24, 2019

Inflammation appears as high Prostate Imaging-Reporting and Data System scores on prostate magnetic resonance imaging (MRI) leading to false positive MRI fusion biopsy. October 24, 2019

Evaluation of the residual prostate cancer rate on cystoprostatectomy specimen in patients treated with radiotherapy for prostate cancer. October 23, 2019

Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis. October 23, 2019

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer. October 23, 2019

Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer. October 23, 2019

Efficacy and safety of 177Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia - A prospective study. October 23, 2019

Page 6 of 1018

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.